Clinical Trials · NCT01089569
Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- HealthPartners Institute
- Enrollment
- 60
- Start date
- Apr 2010
- Locations
- 1 site, United States
- Primary endpoint
- HbA1c Change